Literature DB >> 15728305

Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease.

Y Jeong1, K C Park, S S Cho, E J Kim, S J Kang, S E Kim, E Kang, D L Na.   

Abstract

Frontotemporal dementia (FTD) often coexists with motor neuron disease (MND). To characterize glucose hypometabolism in patients with FTD with MND (FTD/MND), the authors compared the glucose metabolism of 8 patients with FTD/MND with that of 29 patients with FTD. All of the patients with FTD/MND showed glucose hypometabolism only in the frontal area, whereas most patients with FTD had hypometabolism in the frontal and temporal areas. FTD/MND also showed a more symmetric pattern of glucose hypometabolism than FTD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728305     DOI: 10.1212/01.WNL.0000152047.58767.9D

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

Review 1.  [Frontotemporal dementias].

Authors:  K Witt; G Deuschl; T Bartsch
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

2.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

Review 3.  The relationship between amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  George M Ringholz; Scott R Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

4.  Degeneration of the mid-cingulate cortex in amyotrophic lateral sclerosis detected in vivo with MR spectroscopy.

Authors:  N Sudharshan; C Hanstock; B Hui; T Pyra; W Johnston; S Kalra
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-18       Impact factor: 3.825

5.  Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration.

Authors:  Jennifer L Whitwell; Clifford R Jack; Matthew L Senjem; Keith A Josephs
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

Review 6.  Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review.

Authors:  Maria Teresa Giordana; Patrizia Ferrero; Silvia Grifoni; Alessia Pellerino; Andrea Naldi; Anna Montuschi
Journal:  Neurol Sci       Date:  2010-10-16       Impact factor: 3.307

Review 7.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

8.  Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.

Authors:  Jordi A Matías-Guiu; Vanesa Pytel; María Nieves Cabrera-Martín; Lucía Galán; María Valles-Salgado; Antonio Guerrero; Teresa Moreno-Ramos; Jorge Matías-Guiu; José Luis Carreras
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-04       Impact factor: 9.236

Review 9.  Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.

Authors:  Federica Agosta; Daniele Altomare; Cristina Festari; Stefania Orini; Federica Gandolfo; Marina Boccardi; Javier Arbizu; Femke Bouwman; Alexander Drzezga; Peter Nestor; Flavio Nobili; Zuzana Walker; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-01       Impact factor: 9.236

10.  Prospective memory tasks: a more sensitive method for screening cognitive impairment in ALS?

Authors:  Ying Ji; Ling Wei; Dehua Chui; Kai Wang; Dongsheng Fan
Journal:  BMC Neurol       Date:  2012-11-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.